Table 3 Oocytes characteristic features before and after treatment with platelet-rich plasma (PRP) in for POSEIDON groups
Variables | POSEIDON 1 Median ± IQR | POSEIDON 2 Median ± IQR | POSEIDON 3 Median ± IQR | POSEIDON 4 Median ± IQR | P-value | |
|---|---|---|---|---|---|---|
Total Ovocyte number | Before PRP | 4.00 ± 2.00 | 2.00 ± 3.00 | 1.00 ± 3.00 | 1.00 ± 1.00 | 0.003╪ |
After PRP | 9.00 ± 5.00 * | 5.00 ± 5.00 * | 2.00 ± 7.00 * | 3.00 ± 4.00 *** | < 0.001╪ | |
GV Ovocyte number | Before PRP | 1.00 ± 2.00 | 0.00 ± 0.5 | 0.00 ± 1.00 | 0.00 ± 0.00 | 0.003╪ |
After PRP | 0.00 ± 0.00 | 0.00 ± 1.00 | 0.00 ± 0.75 | 0.00 ± 0.00 | 0.085┼ | |
MI Ovocyte number | Before PRP | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.175┼ |
After PRP | 1.00 ± 1.00 | 0.00 ± 1.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.007┼ | |
MII Ovocyte number | Before PRP | 2.00 ± 3.00 | 2.00 ± 3.00 | 1.00 ± 3.00 | 1.00 ± 2.00 | 0.052╪ |
After PRP | 8.00 ± 3.00 * | 4.00 ± 3.50 | 2. .00 ± 6.50 * | 2.00 ± 3.75 *** | 0.001╪ | |
Fetus number | 17.00 ± 13.00 | 4.00 ± 5.00 | 3.00 ± 8.75 | 2.00 ± 6.00 | 0.005╪ | |
Pregnancy | 5/7 (71.42%) | 2/17 (11.76%) | 1/16 (6.25%) | 6/56 (10.71%) | 0.002┼ |